{
    "2019-08-05": [
        [
            {
                "time": "2019-08-02",
                "original_text": "【医药】江琦、池陈森：2019年8月月报：不确定性中寻找确定性，创新与升级两大方向-20190802",
                "features": {
                    "keywords": [
                        "医药",
                        "创新",
                        "升级",
                        "不确定性",
                        "确定性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-02",
                "original_text": "创新药研发的浪潮，方达控股是否会成为下一个药明康德？",
                "features": {
                    "keywords": [
                        "创新药",
                        "研发",
                        "方达控股",
                        "药明康德"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}